Today, the SVP, Process Improvement of Wright Medical Group (NASDAQ: WMGI), Jennifer Walker, bought shares of WMGI for $727.5K.
See today’s analyst top recommended stocks >>
Based on Wright Medical Group’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $199 million and GAAP net loss of $19.91 million. In comparison, last year the company earned revenue of $177 million and had a GAAP net loss of $36.71 million. Currently, Wright Medical Group has an average volume of 871.1K.
19 different firms, including B.Riley FBR and Barclays, currently also have a Buy rating on the stock. Based on 4 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $31.00, reflecting a -16.6% downside.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Wright Medical Group NV operates as a global medical device company, which engages in the design, manufacture, and distribution of biologic products. It provides surgical solutions for the foot and ankle market and its products include large joint implants for the hip and knee, extremity implants for the shoulder, elbow, hand, wrist and foot and biologic products, including bone graft substitutes. The company was founded by Frank O. Wright in 1950 and is headquartered in Arlington, TN.
